The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics

Por Wilson, David P., Coplan, Paul M., Wainberg, Mark A., Blower, Sally M.
Publicado em 2008

Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics

Por Coplan, Paul M, Kale, Hrishikesh, Sandstrom, Lauren, Landau, Craig, Chilcoat, Howard D
Publicado no Pharmacoepidemiol Drug Saf (2013)

Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation†

Por Sessler, Nelson E, Downing, Jerod M, Kale, Hrishikesh, Chilcoat, Howard D, Baumgartner, Todd F, Coplan, Paul M
Publicado no Pharmacoepidemiol Drug Saf (2014)

Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent pro...

Por Janoff, Shannon L., Perrin, Nancy A., Coplan, Paul M., Chilcoat, Howard D., Campbell, Cynthia I., Green, Carla A.
Publicado no BMC Pharmacol Toxicol (2016)

ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes

Por Cepeda, M. Soledad, Coplan, Paul M., Kopper, Nathan W., Maziere, Jean-Yves, Wedin, Gregory P., Wallace, Laura E.
Publicado no Pain Med (2017)

Monitoring of Internet Forums to Evaluate Reactions to the Introduction of Reformulated OxyContin to Deter Abuse

Por McNaughton, Emily C, Coplan, Paul M, Black, Ryan A, Weber, Sarah E, Chilcoat, Howard D, Butler, Stephen F
Publicado em 2014